These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
235 related items for PubMed ID: 25531939
21. Discovery and characterization of non-ATP site inhibitors of the mitogen activated protein (MAP) kinases. Comess KM, Sun C, Abad-Zapatero C, Goedken ER, Gum RJ, Borhani DW, Argiriadi M, Groebe DR, Jia Y, Clampit JE, Haasch DL, Smith HT, Wang S, Song D, Coen ML, Cloutier TE, Tang H, Cheng X, Quinn C, Liu B, Xin Z, Liu G, Fry EH, Stoll V, Ng TI, Banach D, Marcotte D, Burns DJ, Calderwood DJ, Hajduk PJ. ACS Chem Biol; 2011 Mar 18; 6(3):234-44. PubMed ID: 21090814 [Abstract] [Full Text] [Related]
22. High-throughput screening for novel inhibitors of Neisseria gonorrhoeae penicillin-binding protein 2. Fedarovich A, Djordjevic KA, Swanson SM, Peterson YK, Nicholas RA, Davies C. PLoS One; 2012 Mar 18; 7(9):e44918. PubMed ID: 23049763 [Abstract] [Full Text] [Related]
23. Characterization of H-box region mutants of WalK inert to the action of waldiomycin in Bacillus subtilis. Kato A, Ueda S, Oshima T, Inukai Y, Okajima T, Igarashi M, Eguchi Y, Utsumi R. J Gen Appl Microbiol; 2017 Sep 05; 63(4):212-221. PubMed ID: 28674376 [Abstract] [Full Text] [Related]
24. Bacterial Histidine Kinases: Overexpression, Purification, and Inhibitor Screen. Gajdiss M, Türck M, Bierbaum G. Methods Mol Biol; 2017 Sep 05; 1520():247-259. PubMed ID: 27873257 [Abstract] [Full Text] [Related]
25. Evaluation of small molecule kinase inhibitors as novel antimicrobial and antibiofilm agents. King A, Blackledge MS. Chem Biol Drug Des; 2021 Dec 05; 98(6):1038-1064. PubMed ID: 34581492 [Abstract] [Full Text] [Related]
26. Protein kinases as antibacterial targets. Schreiber M, Res I, Matter A. Curr Opin Cell Biol; 2009 Apr 05; 21(2):325-30. PubMed ID: 19246185 [Abstract] [Full Text] [Related]
27. Small molecule inhibitors of bacterial transcription complex formation. Wenholz DS, Zeng M, Ma C, Mielczarek M, Yang X, Bhadbhade M, Black DSC, Lewis PJ, Griffith R, Kumar N. Bioorg Med Chem Lett; 2017 Sep 15; 27(18):4302-4308. PubMed ID: 28866270 [Abstract] [Full Text] [Related]
28. Structural and mutational analysis of the PhoQ histidine kinase catalytic domain. Insight into the reaction mechanism. Marina A, Mott C, Auyzenberg A, Hendrickson WA, Waldburger CD. J Biol Chem; 2001 Nov 02; 276(44):41182-90. PubMed ID: 11493605 [Abstract] [Full Text] [Related]
29. Repurposing Hsp90 inhibitors as antimicrobials targeting two-component systems identifies compounds leading to loss of bacterial membrane integrity. Fernandez-Ciruelos B, Albanese M, Adhav A, Solomin V, Ritchie-Martinez A, Taverne F, Velikova N, Jirgensons A, Marina A, Finn PW, Wells JM. Microbiol Spectr; 2024 Aug 06; 12(8):e0014624. PubMed ID: 38917423 [Abstract] [Full Text] [Related]
30. A small molecule discrimination map of the antibiotic resistance kinome. Shakya T, Stogios PJ, Waglechner N, Evdokimova E, Ejim L, Blanchard JE, McArthur AG, Savchenko A, Wright GD. Chem Biol; 2011 Dec 23; 18(12):1591-601. PubMed ID: 22195561 [Abstract] [Full Text] [Related]
31. Putative histidine kinase inhibitors with antibacterial effect against multi-drug resistant clinical isolates identified by in vitro and in silico screens. Velikova N, Fulle S, Manso AS, Mechkarska M, Finn P, Conlon JM, Oggioni MR, Wells JM, Marina A. Sci Rep; 2016 May 13; 6():26085. PubMed ID: 27173778 [Abstract] [Full Text] [Related]
32. An immuno-dot blot assay for screening histidine kinase inhibitors. Kinoshita-Kikuta E, Maruta S, Eguchi Y, Igarashi M, Okajima T, Utsumi R, Kinoshita E, Koike T. Anal Biochem; 2020 Jul 01; 600():113765. PubMed ID: 32360198 [Abstract] [Full Text] [Related]
33. Study on in vivo effects of bacterial histidine kinase inhibitor, Waldiomycin, in Bacillus subtilis and Staphylococcus aureus. Fakhruzzaman M, Inukai Y, Yanagida Y, Kino H, Igarashi M, Eguchi Y, Utsumi R. J Gen Appl Microbiol; 2015 Jul 01; 61(5):177-84. PubMed ID: 26582287 [Abstract] [Full Text] [Related]
34. Small-molecule inhibition of bacterial two-component systems to combat antibiotic resistance and virulence. Worthington RJ, Blackledge MS, Melander C. Future Med Chem; 2013 Jul 01; 5(11):1265-84. PubMed ID: 23859207 [Abstract] [Full Text] [Related]
35. ATP Binding as a Key Target for Control of the Chemotaxis Kinase. Jun SY, Pan W, Hazelbauer GL. J Bacteriol; 2020 Jun 09; 202(13):. PubMed ID: 32341073 [Abstract] [Full Text] [Related]
36. The histidine kinase inhibitor Sda binds near the site of autophosphorylation and may sterically hinder autophosphorylation and phosphotransfer to Spo0F. Cunningham KA, Burkholder WF. Mol Microbiol; 2009 Feb 09; 71(3):659-77. PubMed ID: 19040634 [Abstract] [Full Text] [Related]
37. Inhibition of the signal transduction through the AtoSC system by histidine kinase inhibitors in Escherichia coli. Theodorou EC, Theodorou MC, Kyriakidis DA. Cell Signal; 2011 Aug 09; 23(8):1327-37. PubMed ID: 21443947 [Abstract] [Full Text] [Related]
38. Fluorescence labels in kinases: a high-throughput kinase binding assay for the identification of DFG-out binding ligands. Simard JR, Rauh D. Methods Mol Biol; 2012 Aug 09; 800():95-117. PubMed ID: 21964785 [Abstract] [Full Text] [Related]
39. Light-assisted small-molecule screening against protein kinases. Inglés-Prieto Á, Reichhart E, Muellner MK, Nowak M, Nijman SM, Grusch M, Janovjak H. Nat Chem Biol; 2015 Dec 09; 11(12):952-4. PubMed ID: 26457372 [Abstract] [Full Text] [Related]
40. Identification and characterization of novel small molecule inhibitors of the acetyltransferase activity of Escherichia coli N-acetylglucosamine-1-phosphate-uridyltransferase/glucosamine-1-phosphate-acetyltransferase (GlmU). Sharma R, Rani C, Mehra R, Nargotra A, Chib R, Rajput VS, Kumar S, Singh S, Sharma PR, Khan IA. Appl Microbiol Biotechnol; 2016 Apr 09; 100(7):3071-85. PubMed ID: 26563552 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]